A new study reveals that a combination of molecular imaging, radiography, and dual imaging probes detects more cancerous bone lesions than other methods. The addition of molecular imaging with combined radiopharmaceuticals to conventional CT improves the power of imaging for cancer diagnosis.
A new molecular imaging method using PET/CT with Gallium-68 DOTATATE identifies hormonally active tissues, allowing clinicians to re-evaluate patient management. This technique changes treatment plans in over 35% of patients, saving them from unnecessary surgeries.
Research finds that combining molecular imaging with computed tomography (CT) can reduce patient radiation dose. By using just one CT scan for multiple PET studies, researchers lower radiation exposure and improve image quality.
A study suggests that women can reduce their breast cancer risk by avoiding unnecessary medical imaging. According to the UCSF analysis of IOM report, radiation exposure from medical imaging is a known risk factor for breast cancer.
Piramal Imaging will present data from five florbetaben studies, including a pivotal Phase III trial that will provide the basis for regulatory submission later this year. The company is developing an innovative and proprietary tracer portfolio to address major clinical needs in Alzheimer's disease and other conditions.
Researchers investigated whether preoperative imaging differed between black and white women with breast cancer. They found no disparity in the use of imaging, contrary to some earlier studies. However, they did note that women from more educated areas were more likely to receive certain types of imaging.
A multicenter study found that the Breast Imaging and Reporting Data Systems (BI-RADS) terminology used by radiologists is useful in predicting malignancy in breast lesions detected with MRI. Features such as irregular shape, spiculated margins, and marked enhancement are most predictive of cancer.
A recent study by Brigham and Women's Hospital found that unnecessary imaging recommendations in PET/CT oncologic reports are common, with 43 out of 84 recommendations being deemed unnecessary. This highlights the need for radiologists to reduce frequency of additional imaging tests without compromising patient outcomes.
A recent study found that radiologists recommended additional imaging in 30% of PET/CT oncologic reports, with half being unnecessary. The study suggests that reluctance to accept uncertainty and medicolegal concerns contribute to these recommendations.
Researchers build 'spaghetti models' of cancer progression using mathematical models, predicting tumor growth, response to treatments, and risk of recurrence. This approach combines clinical imaging with biological experiments and mathematical modeling to develop patient-specific medicine.
Researchers at McLean Hospital have developed a new category of nanoparticles that can non-invasively cross the blood-brain barrier, transporting various types of drugs. These nanoparticles also outperform existing MRI contrast agents, offering a significant improvement in imaging performance and reduced gadolinium toxicity.
Researchers developed a computational technique to correct aberrations in optical tomography, enabling faster, less expensive and higher resolution tissue imaging. The technique was demonstrated using gel-based phantoms and rat lung tissue, resulting in sharp points and clearer tissue structures.
Researchers at the University of Toronto have created a new neural imaging system that allows for more complex maps of brain functions with just one camera and imaging system. This technology uses vertical cavity surface emitting lasers to classify veins and arteries simultaneously.
A study found that patients with inflammatory bowel disease and other gastrointestinal disorders receive significant doses of diagnostic radiation. Alternative, radiation-free imaging options are available, but evidence-based guidelines on reducing radiation exposure are still needed.
A recent study published in Radiology shows that tomosynthesis is more beneficial in diagnosing knee osteoarthritis than conventional X-ray imaging. The study detected more osteophytes and subchondral cysts in the knee joint, improving sensitivity by up to 29% and 50% respectively.
The University of Colorado has developed a novel technique for 3D super-resolution imaging with the help of Boulder-based Double Helix LLC. This technology combines 3D optics and signal processing to provide multifunctional imaging capability, applicable to various scientific, industrial, and consumer applications.
Imaging amino acid transporters with PET/CT has significantly altered management plans for 41% of patients with brain tumors, according to research. The imaging modality has improved detection of primary and recurrent high- and low-grade brain tumors, leading to changes in treatment from 'watch and wait' to chemotherapy or vice versa.
A new technique, virtual ghost imaging (VGI), enables imaging even under adverse conditions by harnessing the properties of entangled photons. Researchers used a Bessel beam to create VGI images despite obstacles such as clouds, heat distortion, and offsets.
The new hybrid scanner combines MRI and PET technology to capture minute details and produce superior three-dimensional images. It will be used to diagnose cardiovascular disease, neurological diseases, mental health, and cancer more accurately and efficiently.
Researchers use molecular imaging to improve diagnosis and treatment decisions for estrogen-receptor positive breast cancer patients, detecting bone metastases and predicting therapy response. PET imaging with 18F-FES and 18F-FDG improves diagnostic information and prompts changes in treatment for 88% and 48% of subjects respectively.
A large hospital implemented a CPOE system with clinical decision support for radiology, significantly increasing meaningful use and adoption rates. The study observed a decrease in low-utility imaging studies by up to 57%.
The Massachusetts Life Sciences Center awarded Dana-Farber Cancer Institute a $10 million grant to support the expansion of its pioneering cancer imaging research program. The new facility will enable better diagnosis, targeted therapies, and improved patient outcomes.
The Galileo program seeks to bridge the precision fiber optic controls and long-baseline astronomical interferometry technical communities to enable faster imaging of objects in geosynchronous orbit. By harnessing the power of flexible fiber optics, researchers aim to create a new means of better, faster imaging of objects in GEO.
Despite virtual imaging advancements, traditional autopsies are still essential for determining cause of death. Current imaging technologies often miss common diagnoses when compared to autopsy findings.
A study found that uninsured patients receiving imaging services in a hospital setting received the same quantity and value as insured patients. Despite this, uninsured individuals were less likely to undergo interventional procedures but more likely to receive computed tomography studies.
A new PET technique using FLT-PET has shown highly sensitive imaging for patients with mantle cell lymphoma, a relatively rare and devastating blood cancer. The study found that all cancerous lesions were very highly visible using FLT-PET, providing a powerful biomarker for MCL.
Researchers found that between 1992 and 2005, the percentage of patients who had multiple imaging visits nearly quadrupled, from 4.9% to 19.4%. A single imaging visit increasingly includes multiple types of imaging, with the rate rising from 4.3% to 27.1%.
A new molecular imaging probe using ghrelin exploits the hunger hormone's unique consumption pattern by malignant prostate cancer cells. The test showed the signal was almost 5 times stronger in malignant cancer cells than in normal or benign cells.
Researchers have developed a new imaging technique to track both metallic and semiconducting single-wall carbon nanotubes in live cells and the bloodstream. This 'label-free' approach uses transient absorption to visualize the nanotubes in real-time, overcoming key obstacles in previous methods.
A study found that physicians with financial interest in imaging equipment refer more patients for unnecessary MRI exams, leading to increased healthcare costs. The study revealed a higher rate of negative scans and younger patients among those referred by financially interested physicians.
Scientists have created a novel combination of additives that enable gelatin to mimic the acoustical and optical properties of soft tissue in humans. The resulting tissue 'phantoms' can be used to test photoacoustic and ultrasonic imaging technologies, which are increasingly being used in clinical applications.
A study found that post-mortem imaging can identify cause of death in two-thirds of cases, with CT being more accurate than MRI. However, common causes of sudden death are frequently missed, and further development is needed to address these weaknesses.
Professor Boppart discusses the importance of federal funds for research in medical imaging, enabling diagnosis and improving healthcare. He highlights the potential of optical coherence tomography to reduce re-operations and develop compact imaging devices for primary care physicians.
A new study found that spinal bleeding is common in young children with traumatic brain injury, suggesting abusive trauma. Complete spine imaging can help distinguish between abusive and accidental injury in these cases. The study's findings support the importance of imaging the whole spine for accurate diagnosis.
Novel imaging agents detectable by PET imaging may visualize tumors in their earliest stages, enabling early detection and treatment of cancer. The compounds target COX-2, an enzyme found in inflammatory lesions and tumors.
A new hybrid imaging device combining photoacoustic imaging, optical coherence tomography, and pulse-echo ultrasound has been developed to diagnose early-stage ovarian cancer. The device was tested on both pig and human ovarian tissue, correctly identifying malignant tumors in initial tests.
The Ohio Third Frontier Commission has awarded $2.5 million to advance two significant imaging research projects at the Philips Healthcare Global Advanced Imaging Innovation Center, a collaboration among University Hospitals Case Medical Center and Case Western Reserve University.
The Wellcome Trust report highlights progress in human functional brain imaging, including breakthroughs in statistical and computational modeling. The review emphasizes the need for continued funding and collaborations to translate findings into clinical applications.
Researchers at MIT have developed a new high-speed 3D imaging system based on optical coherence tomography (OCT) technology, enabling real-time visualization of microscopic features in the esophagus and colon. The system promises to improve cancer screening by detecting pre-cancerous changes and guiding endoscopic therapies.
A novel imaging technique combines high resolution, high penetration depth, and high imaging speed to capture detailed information from live biological samples without damaging them. The technique uses two-photon excitation in sheet-illumination mode, enabling fast imaging speed and reducing light-induced damage.
The investigational amyloid imaging agent [18F]Flutemetamol showed highly consistent image interpretation and comparable in vitro binding to Pittsburgh Compound-B, according to recent clinical research data. Flutemetamol is being studied for the detection of beta amyloid using PET brain scans.
A recent study found that self-referral in medical imaging contributes to increased diagnostic imaging growth, with a 59.7% utilization rate of imaging services attributed to non-radiologist self-referers. The study estimates $3.6 billion in excess costs to Medicare Part B annually due to unnecessary imaging.
A study found that non-gated PET imaging with 4D computed tomography can produce more accurate tumor imaging for patients with irregular breathing. This approach may improve overall accuracy of tumor detection and inform clinicians about appropriate treatments.
Researchers have successfully used oatmeal products radiolabeled with a medical isotope to image stomach emptying in molecular imaging studies. The study demonstrated that prior boiling and labeling of oatmeal improves radiolabeling efficiency, making it an effective alternative to egg meal for patients with dietary restrictions.
A study found that gamma imaging outperformed ultrasound in detecting breast cancer, especially in women with dense breast tissue. Gamma imaging provided 100% sensitivity and 82% specificity, leading to a better prognosis for breast cancer patients.
Researchers developed a molecular imaging technique that can detect reduced blood flow in diabetic hearts, potentially saving lives. The study found that this method is safe and beneficial for predicting cardiac events in diabetic patients suspected of having ischemic heart disease.
A molecular imaging procedure using PET/CT and F18 NaF radiotracer accurately diagnoses and manages chronic back pain by pinpointing the source of abnormal bone reaction. In a study, this method was found to be highly effective in more than 85% of cases, providing relief for patients with hardware implants or bone grafts.
A new study found a significant correlation between high BMI and decreased aromatase availability in the brains of overweight subjects. This suggests that low estrogen levels may lead to reduced control over appetite and food intake, resulting in weight gain.
A new imaging agent called 18F FPPRGD2 targets breast tumor development by detecting angiogenesis, a process that forms new blood vessels in tissues. This allows for better clinical decisions and earlier identification of patients who are ideal candidates for aggressive therapies.
Researchers found that PET/CT imaging with the radiotracer 18F-FDG successfully detected 84% of benign and malignant tumors in patients with adnexal masses. This technology helps predict cancer stage and provide better treatment options for women diagnosed with ovarian cancer.
The study presents promising results for the clinical use of a new integrated PET/MRI system, which provides diagnostic information on soft tissues and physiological functions. The technology has been shown to be comparable in detecting cancerous tumors as conventional PET/CT methods.
A new molecular imaging agent has been developed to detect tumor angiogenesis, a process of rapid blood vessel growth associated with malignant cancers. The agent, which targets the CD105 protein biomarker, shows promising results in early studies, including high uptake by tumors in mice.
Researchers combined two molecular imaging agents to create a powerful new tool for acquiring information about the extent of a patient's cancer. The results showed that combined 18F NaF and 18F FDG PET/CT imaging provided good-quality imaging of both skeletal and extra-skeletal malignant lesions from various cancers.
A study in the Journal of the American College of Radiology found that patient age and facility imaging capacity significantly impact MRI use. Hospitals with limited access to scanning technologies had less frequent use of MRI scans.
Cardiac patients can now receive a reduced radiation dose during diagnostic perfusion imaging, thanks to new image-processing software. The study found that images produced with a half-dose protocol were of similar quality to those obtained with conventional protocols, while reducing the patient's exposure to radiation.
Researchers found that combining ultrasound with pre-operative MRI is a cost-effective strategy for evaluating rotator cuff tears. The study showed that this hybrid approach can be more cost-effective than using MRI alone, especially in populations with lower pre-test probabilities of rotator cuff tear.
Scientists have developed a new imaging agent using tantalum oxide nanoparticles, which stays in the body long enough to image multiple organs. The material is inexpensive and has shown promising results in laboratory tests, potentially overcoming limitations of existing imaging agents.
A new study found that implementing a system to upload CD images of emergency transfer patients into the receiving institution's picture archiving and communication system (PACS) decreased subsequent imaging rates by 17%. This reduces unnecessary medical imaging tests, some of which expose patients to radiation.
Researchers at Cardiff University have developed a 'sleeping Trojan horse' delivery system that enables the efficient transport of metal ions into cells, opening up new possibilities for medical imaging. This innovative approach resolves some of the difficulties associated with traditional 'Trojan Horse' techniques.
Researchers found ultrasound fusion imaging to be safe and effective in detecting bone and soft tissue cancers, with 93% accuracy compared to CT biopsies. The technique guides a needle biopsy with precise accuracy, making the experience more convenient for patients.